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ABSTRACT: 
 
Introduction: Peritonsillar abscess (PTA) is a common infectious complication of pharyngeal infection 
managed by otolaryngologists and emergency room physicians. Streptococcus and Fusobacterium (e.g., 
Fusobacterium necrophorum, FN) species are commonly isolated pathogens. The aim of this study was 
to determine the implication of culture results on abscess recurrence following drainage.   
Methods: Single-institution retrospective review of patients treated at the University of Michigan 
between 2000 and 2017. Demographic and clinical outcome data were analyzed, including treatment 
details, culture data, and recurrence.  
Results: 156 of the 990 patients in our study developed recurrence of their abscess (16%). The age 
ranges most susceptible to recurrence included adolescent (22.9%) and young adult groups (17.1%). 
Recurrent patients were more likely to have experienced acute progression of symptoms (79% vs 71%, p 
= 0.03), trismus (67% vs 55%, p = 0.006), voice changes (65% vs 57%, p = 0.04) and dysphagia (72% vs 
61%, p = 0.01) compared to non-recurrent patients. They were also more likely to have clinical 
lymphadenopathy noted on initial examination (67% vs 56%, p = 0.009). Culture data was sent for 852 
patients (86%). The presence of FN was significantly more prevalent in the recurrent group (p < 0.0001). 
Conclusion: There is a high observed prevalence of FN species within PTA aspirates in the recurrent PTA 
population. PTA aspirate should be sent for anaerobic growth to screen for Fusobacterium species. In 
addition, follow-up and lower threshold for subsequent tonsillectomy should be considered in this at-
risk group.   
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Abbreviations: 
 FN  Fusobacterium necrophorum 
 ITA  Intratonsillar abscess 
PTA  Peritonsillar abscess 
SA   Streptococcus anginosus  
 
Key Words:  Peritonsillar abscess, Intratonsillar abscess, Otolaryngology, Fusobacterium necrophorum, 
Streptococcus anginosus  
 
Level of Evidence: 3, retrospective comparative analysis  
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INTRODUCTION: 
Peritonsillar abscess (PTA) is the most commonly occurring abscess in the head and neck region. There is 
an annual incidence of 30 cases per 100,000 inhabitants in the United States, or a total of approximately 
45,000 cases per year1. The typical management of PTAs includes needle aspiration and drainage and is 
occasionally followed by formal incision and dissection of the peritonsillar space2. Adjunctive measures 
can include intravenous fluids, steroids, analgesic medications, and antibiotics. Although less common in 
contemporary times, surgical drainage or performance of quinsy tonsillectomy is occasionally performed 
for urgent evacuation of purulence in select patients3-5. Persistent disease or development of a recurrent 
abscess can be common, with studies describing recurrence rates ranging from 9.6% to 40%6-8.  
Factors that have been implicated in recurrent peritonsillar abscesses included younger age (16-30 
years), prior history of recurrent tonsillitis, history of prior PTA, longer hospital stay, prior hospitalization 
for antibiotics, and extra-peritonsillar spread on CT imaging6,7,9. The consequence of these risk factors 
may include greater need for follow-up or stronger consideration for tonsillectomy.  
The microbiological characterization of the peritonsillar abscess has also been well-studied, albeit not in 
the context of recurrent disease. In a retrospective review on bacterial cultures from abscess aspirates, 
Mazur et al found that the most frequently isolated pathogenic monoculture was Streptococcus 
pyogenes9. In this retrospective review, the authors aim to characterize risk factors implicated in 
patients with persistent or recurrent peritonsillar abscesses with particular attention paid to the 
pathogens isolated from aerobic and anaerobic cultures.   
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METHODS: 
Study Population 
We performed an IRB-approved single-institution retrospective case series of patients who presented to 
our emergency department or outpatient clinic with suspicion for a deep neck space infection. Patients 
who were diagnosed with a peritonsillar or intratonsillar abscess (ITA) from 2000-2017 were included. 
Diagnostic criteria for the PTA included: radiologist confirmation of debris or abscess within peritonsillar 
space, or evacuation of purulence from peritonsillar space either via bedside procedure or operative 
quinsy tonsillectomy, or clinical diagnosis of early peritonsillar abscess after failed evacuation attempt. 
Diagnostic criteria for the ITA included: radiologist confirmation of debris or abscess within the tonsillar 
parenchyma, or evacuation of purulence from the intratonsillar parenchyma either via bedside 
procedure or operative quinsy tonsillectomy. Patients who did not have a diagnosis of PTA or ITA were 
excluded from the study, as were patients who had infections present within additional spaces of the 
neck (such as concomitant parapharpharyngeal or retropharyngeal abscesses). We excluded patients 
with diagnoses of viral pharyngitis or tonsillitis as interpreted from clinical reports. Herein, if there was 
no imaging performed or no evacuation of purulence after aspiration attempt, cellulitis was 
distinguished from “early” or “developing” abscess based off clinical interpretation of the treating 
provider. Demographics, clinical symptomatology, primary treatment modality, imaging characteristics, 
microbiological growth, and follow-up data were tabulated. Data were collected using clinical notes and 
imaging available in our electronic medical records system.  
Statistical Analysis 
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Standard descriptive statistics were tabulated and bivariate associations with recurrent vs non-recurrent 
cohorts were tested with chi-square tests and t-tests where appropriate. Multivariable modeling was 
performed in two stages. First, all demographic, basic clinical factors and symptomology (listed in Tables 
1 and 2) were considered as potential predictors of recurrence in multivariable logistic regression 
models. Backward selection, with alpha criteria of 0.10, was performed. Second, additional factors for 
which we had subsets of patient information such as WBC count, rapid mono and strep tests were 
tested for significance individually in addition to the parsimonious clinical model. Alpha of 0.05 was 
considered significant and all analyses were performed in SAS v9.4.  
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RESULTS:  
Our study initially identified 1,335 patients with a diagnosis of PTA or ITA. Patients with diagnoses of 
viral pharyngitis, tonsillitis, or other concomitant deep neck space infections, were excluded. From this 
group, 990 patients were remaining. Demographics information for recurrent and non-recurrent groups 
are shown in Table 1. In all, 156 of the 990 patients developed recurrence of their abscess (16%). 
Patients were further sub-categorized into age-ranges; children were categorized as 0-12 years, 
adolescents into 13-18 years, young adults into 19-30 years, and adults were split into 31-50 and 50+ 
years as noted. The age ranges most susceptible to recurrent abscesses included the adolescent (23% 
recurrence rate) and the young adult groups (17% recurrence rate). Recurrent abscesses were 
uncommon in children (7.3% and the 50+ age group (5.8%).  
Clinical information for the two cohorts are displayed in Table 2. There were no significant differences in 
duration of symptoms between the recurrent and non-recurrent groups. From a presenting 
symptomatology perspective, those who developed recurrences were more likely to have initially 
experienced acute progression of symptoms (79% vs 71%, p = 0.03), trismus (67% vs 55%, p = 0.006), 
voice changes (65% vs 57%, p = 0.04) and dysphagia (72% vs 61%, p = 0.01). They were also more likely 
to have clinical lymphadenopathy noted on initial examination (67% vs 56%, p = 0.009).  
Objective laboratory data and culture data is demonstrated in Table 3. There was no statistically 
significant difference between the two cohorts in regards to elevated white blood cell (WBC) count and 
development of recurrence. Rapid Epstein Barr Virus testing was found to be positive in a greater 
proportion of non-recurrent patients (20% vs 9%, p = 0.03). Overall, 494 (50%) patients were treated 
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with Augmentin, 493 (50%) with clindamycin, and 3 with a penicillin (0.4%) at their initial visitation. 
There was no statistically significant difference between the proportion of patients placed on Augmentin 
who experienced a recurrence versus those placed on clindamycin (17% versus 15% respectively, p = 
0.39). 
Culture data is tabulated in Table 4; the microbiological data presented was obtained from the patient’s 
initial visit to the hospital. Among the 990 patients with peritonsillar or intratonsillar abscesses, culture 
data was sent for 566 patients (58%). The remaining patients either did not have purulence aspirated 
with drainage attempt or no culture data was sent. The presence of Fusobacterium necrophorum (FN) 
(67% vs 13%, p < 0.0001) were significantly more prevalent in the recurrent group. There was no 
statistically significant association with presence of Streptococcal species, Eikenella corrodens, 
Bacteroides fragilis, Prevotella species and Staphylococcus aureus species and recurrent PTA. While not 
statistically significant, there was a large proportion of patients with Streptococcus anginosus (SA) with 
recurrent PTA (n = 32, 23%).  
Further analysis of the relationship between FN and SA is demonstrated in Figure 1. For the patients for 
whom culture data was available, only 4% experienced recurrence in the absence of growth of FN or SA. 
For isolated bacteria, there was a 44% recurrence rate with presence of FN only and a 14% recurrence 
rate with presence of isolated SA. The recurrence rate for concomitant growth of FN and SA (42%) was 
similar to recurrence rates for FN only (44%).  
A logistic regression model was utilized to assess odds of recurrence depending on isolated versus 
concomitant FN and SA growth as demonstrated in Table 5. This demonstrates that the odds of 
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recurrence are significantly smaller for lack of growth of FN and SA and for the SA positive only cohorts 
in comparison to the cohort with growth of both FN and SA. The odds of recurrence are similar for FN 
positive only in comparison to FN and SA cohort.   
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DISCUSSION: 
There exists a plethora of potential reasons for persistent or recurrent peritonsillar disease. Early 
recurrences, or persistence of disease, could be related to inadequate treatment (such as inadequate 
drainage of the peritonsillar space), extra-peritonsillar spread of infection, or autoimmune 
deficiency6,7,10. Later recurrences could be related to autoimmune deficiency or prior history of tonsillitis 
or pharyngitis. In this retrospective review, our results indicated that those patients with persistent or 
recurrent disease were more likely to have presented with acutely progressive symptoms, trismus, voice 
changes, dysphagia, and lymphadenopathy. These findings are likely related to the probability that those 
with more severe symptoms – and resultant more severe infections – were more likely to present again 
with symptoms and abscesses that required repeat intervention. There further appeared to be a specific 
age range at which patients with pharyngeal abscesses were more likely to present with recurrent 
disease, specifically the 13-18 age range (23% recurrence rate) and the 19-30 age range (17%). This 
finding may be related to previous findings in the literature that those with a history of recurrent 
tonsillitis were more likely to develop PTAs and recurrent PTAs6.  
The relationship of pathogenic organisms to peritonsillar abscess recurrence has not been previously 
well-studied. Upon initial analysis – although not statistically significant - there did appear to be a 
potential association between Streptococcus anginosus growth and recurrent abscesses. However, 
further characterization demonstrated that the effect appeared to be attributable to concomitant 
growth of FN within those cultures. The SA group consists of morphologically similar strains including 
Streptococcus anginosus, Streptococcus intermedius, and Streptococcus constellatus9. Previous studies 
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have demonstrated no association between streptococcal species, including SA, and recurrent 
peritonsillar disease11.  
In this study, the presence of FN species within such a large proportion of patients with either previous 
peritonsillar abscesses or amongst those who eventually developed recurrent PTAs, certainly suggests a 
relationship between FN and difficult to eradicate peritonsillar disease. While this concept may be novel, 
the presence of FN within head and neck abscess aspirate is not.  
Fusobacterium species, strictly anaerobic gram-negative rods, are primarily isolated from the oral cavity, 
although they can also be found in the abdomen and urogenital tract12. The publication of newer studies 
relating Fusobacterium species and head and neck infections may be related to increased awareness of 
the potential devastating effects of this pathogen, with resultant increased testing.  In a Danish study 
conducted on patient specimens collected between 2010 and 2014, the authors reported that FN was 
present on throat swab in 516 cases per million/year in the 10-19 age range and 302 cases per 
million/year in the 20-29 age range13. In relation to aspirates from PTAs, FN was present in 168 and 116 
cases per million/year in the 10-19 and 20-29 age ranges respectively13. Additional studies offer support 
for routine anaerobic testing of patients with suspected pharyngotonsillitis, citing FN as the most 
prevalent cause of such infections in the 15-30 age group14. A large retrospective review of 847 patients 
demonstrated that FN was the most frequently detected bacteria in PTA culture (present in 23% of 
cultures), in addition to being significantly associated with a younger patient population (median age 18 
years)15. The long-term effects of FN are poorly elucidated, however there is evidence to suggest that 
colonization of this organism may lead to a decrease in the diversity of the tonsillar microbiome16.  
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The implication of FN as a pathogenic driver for recurrent peritonsillar infections and abscesses fits 
within the continuum of our increasing awareness of FN presence with pharyngotonsillar infections and 
well-established knowledge of FN generation of Lemierre syndrome17. It is thus theorized that FN acts to 
colonize the oropharynx and result in recurrent infections/abscesses18,19. There is increasing evidence 
that FN preferentially colonizes or manifests in a specific age-range; in this study we note that the age 
range at greatest risk for recurrence is the 13-18 category. Previous studies have demonstrated that FN-
driven tonsillitis preferentially affects a similar 10-19 age category13. Similarly, the population at greatest 
risk for FN-driven Lemierre syndrome is in the 14-24 age range, with one study demonstrating a median 
age of 18 years20,21. Treatment strategies in this young patient population may need to be reconsidered. 
Initially, based off the findings in this study of the potential significance of certain pathogens, we would 
recommend that all PTA aspirate be sent for aerobic and anaerobic culture. In the event of FN growth, 
the literature as it pertains to antibiotic treatment and duration is largely theoretical and empiric. 
Penicillins, metronidazole, and clindamycin are known to have low minimal inhibitory concentrations for 
FN and resistance is rare14.  
In the absence of pertinent clinical studies, it is difficult to make specific recommendations for 
treatment type and duration. There does appear to be a role for close and dedicated follow-up for these 
patients and possible low threshold to consider tonsillectomy. While none of the recurrent patients in 
our cohort with FN developed Lemierre disease, it is certainly a known and severe possibility.  
Study Limitations 
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The limitations of this study are related to its retrospective nature. As discussed in the Methods section, 
the diagnosis of PTA was based off radiographic, procedural, or clinical findings. Whereas diagnoses 
derived from imaging or evacuation of purulence are largely objective, there is inherent bias in 
diagnosing an abscess in the absence of imaging findings or confirmation via evacuation of purulence 
from an abscess cavity. This relegates the diagnosis of “early” or “developing” abscess versus cellulitis to 
the treating practitioner, which can be inconsistent and potentially incorrect. Thus, this introduces the 
possibility that some of the recurrent PTA cases may have simply represented cellulitis at the time of 
initial treatment, or that the provider may have missed the abscessed cavity on intervention. Further 
limitations stem from the lack of standardized work-up and treatment of suspected PTA cases. This is 
demonstrated in the non-uniform performance of CT imaging, rapid streptococcus testing, EBV testing, 
and even obtainment of culture data from aspirate. While custom analyses were performed for the 
subset of patients who did have the aforementioned testing performed, it is difficult to determine 
definitive conclusions due to this non-standard work-up.    
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CONCLUSION: 
Peritonsillar abscess is the most common neck space abscess; the clinical course and treatment results 
in significant patient distress, lost school/work days, and specialized care. Recurrent PTAs have been 
previously linked to extra-peritonsillar spread on imaging, prolonged hospital stays, prior 
hospitalizations, and younger age range. In this retrospective review, we describe increased prevalence 
of FN within PTA aspirates in the recurrent PTA population. Given this finding, it would be prudent for all 
practitioners to send aspirate for anaerobic growth to screen for FN. In addition, we would recommend 
close and dedicated follow-up with a low threshold to pursue tonsillectomy in this patient population. 
Future prospective studies can better help elucidate the ideal type of antibiotic and duration of 
treatment to implement.   
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Figure Legend: 
 
Table 1. Demographics information 
Table 2. Comparative clinical information for recurrent and non-recurrent groups 
Table 3. Objective information for recurrent and non-recurrent groups 
Table 4. Culture data for recurrent and non-recurrent groups obtained from initial hospital visit 
Table 5. Odds ratio estimates for recurrence risk with Streptococcus anginosus and Fusobacterium 
necrophorum. 
Figure 1. Demonstration of overlap between Streptococcus anginosus and Fusobacterium necrophorum  
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Table 1. Demographic information.  
Patients 
N = 990 
Overall (n, %) No Recurrence (n, %) 
N = 834 
Recurrence (n, %) 
N = 156 
P-value 
Age (mean, median, range) 24.3, 20.5, 1.2-88 24.8, 21.0, 1.2-88 21.8, 19.0, 6-65 <0.001 
Age group 0-12 82 (8%) 76 (9.1%) 6 (3.8%) <0.01 
Age group 13-18 253 (26%) 195 (23.3%) 58 (37%) <0.001 
Age group 19-30 432 (44%) 358 (43%) 74 (47%) 0.30 
Age group 31-50 171 (17%) 156 (19%) 15 (9.6%) <0.001 
Age group 51+ 52 (5%) 49 (5.9%) 3 (1.9%) <0.01 
Male gender 504 (51%) 426 (51%) 78 (50%) 0.80 
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Table 2. Comparative clinical information for recurrent and non-recurrent groups.  
Patients 
N = 990 
 Overall (n, %) No Recurrence (n, %) 
N = 834 
Recurrence (n, %) 
N = 156 
P-value 
Duration of 
symptoms 
≤3 days 293 (30%) 256 (31%) 37 (23%) 0.12 
 4-7 days 479 (48%) 402 (48%) 77 (49%) 0.81 
 >7 days 218 (22%) 176 (21%) 42 (27%) 0.13 
Fever  427 (43%) 363 (44%) 64 (41%) 0.56 
Sore throat  990 (100%) 834 (100%) 156 (100%) - 
Worsening of 
symptoms 
 716 (72%) 592 (71%) 124 (79%) 0.03 
Otalgia  577 (58%) 478 (57%) 99 (63%) 0.15 
Trismus  561 (57%) 457 (55%) 104 (67%) 0.006 
Cough  58 (6%) 51 (6%) 7 (5%) 0.43 
Voice change  574 (58%) 472 (57%) 102 (65%) 0.04 
Dysphagia  624 (63%) 512 (61%) 112 (72%) 0.01 
Dyspnea  47 (5%) 40 (5%) 7 (5%) 0.87 
Anorexia  468 (47%) 387 (46%) 81 (52%) 0.21 
Neck pain  192 (19%) 160 (19%) 32 (21%) 0.70 
Lymphadenopathy  573 (58%) 468 (56%) 105 (67%) 0.009 
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Table 3. Objective information for recurrent and non-recurrent groups.  
Patients 
 
 Overall (n, %) No Recurrence (n, %) 
 
Recurrence (n, %) 
 
P-value 
White blood cell 
count (N=734) 
Normal (<11.0) 184 (25%) 161 (26%) 23 (20%) 0.17 
 Elevated (>11.0) 550 (75%) 458 (74%) 92 (80%) 0.19 
Rapid tests      
Mononucleosis 
(N=451) 
Positive 83 (18%) 76 (20%) 7 (9%) 0.03 
Streptococcus, 
(N=694) 
Positive 124 (18%) 111 (19%) 13 (13%) 0.12 
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Table 4. Culture data for recurrent and non-recurrent groups. 
Patients  
N = 566 
Overall (n, %) No Recurrence (n, %),  
N = 447 
Recurrence (n, %),  
N = 119 
P-value 
Any streptococcus species 203 (35%) 159 (35%) 44 (37%) 0.68 
Beta-hemolytic 
streptococcus group A 
51 (9%) 42 (9.4%) 9 (7.6%) 0.61 
Beta-hemolytic 
streptococcus group C 
5 (<1%) 4 (0.9%) 1 (0.8%) 0.72 
Streptococcus agalactiae 3 (<1%) 2 (0.4%) 1 (0.8%) 0.13 
Streptococus pneumoniae 3 (<1%) 2 (0.4%) 1 (0.8%) 0.13 
Streptococcus anginosus 
group 
140 (24%) 108 (24%) 32 (27%) 0.51 
Fusobacterium 
necrophorum 
176 (31%) 99 (22%) 77 (65%) <0.00001 
Prevotella species 67 (12%) 55 (12%) 12 (10%) 0.52 
No growth of organisms 76 (9%) 68 (15%) 8 (7%) 0.005 
Fusobacterium nucleatum 
 
27 (5%) 25 (5.6%) 2 (1.7%) 0.14 
Staphylococcus aureus 20 (4%) 15 (3.4%) 5 (4.2%) 0.69 
Eikenella corrodens 15 (3%) 11 (2.4%) 4 (3.4%) 0.58 
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Table 5. Odds ratio estimates for recurrence risk with Streptococcus anginosus and Fusobacterium 
necrophorum. 
Effect Point 
Estimate 
95% Wald 
Confidence Limits 
FN† and SA‡ negative versus FN and SA positive 0.060 0.029 0.125 
FN positive only versus FN and SA positive  1.107 0.552 2.221 
SA positive only versus FN and SA positive 0.234 0.102 0.537 
† = Fusobacterium necrophorum (FN); ‡ = Streptococcus anginosus (SA) 
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